MUC-031 is a novel thiol-saccharide mucolytic drug. It is potent and fast-acting in rheology-based sputum assays, and improves mucus obstruction, airway inflammation and survival in a mouse model of muco-obstructive lung disease. Read the article in full at erj.ersjournals.com
No comments:
Post a Comment